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Low-frequencyultrasounds(US)areusedtoenhancedrugtransdermaltransport.Althoughthisphenomenonhasbeenextensively
analyzed, information on US eﬀects on the single skin cell components is limited. Here, we investigated the possible eﬀects of low-
frequency US on viability and immune functions of cultured human keratinocytes and dendritic cells (DC), skin cells involved
in the regulation of many immune-mediated dermatoses. We demonstrated that US, employed at low-frequency (42KHz) and
low-intensity (0.15W/cm2) values known to enhance drug and water transdermal transport, did not aﬀect extracellular-signal-
regulated-kinase (ERK)1/2 activation, cell viability, or expression of adhesion molecules in cultured keratinocytes. Moreover, US
at these work frequency and intensity did not inﬂuence the keratinocyte expression and release of immunomodulatory molecules.
Similarly,culturedDCtreatedwithlow-frequencylow-intensityUSwereviable,anddidnotshowanalteredmembranephenotype,
cytokine proﬁle, nor antigen presentation ability. However, intensity enhancement of low-frequency US to 5W/cm2 determined
an increase of the apoptotic rate of both keratinocytes and DC as well as keratinocyte CXCL8 release and ERK1/2 activation, and
DC CD40 expression. Our study sustains the employment of low-frequency and low-intensity US for treatment of those immune
skin disorders, where keratinocytes and DC have a pathogenetic role.
Copyright © 2009 Claudia Scarponi et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Skin is a very eﬃcient barrier against external agent penetra-
tion. Low permeability is attributed to the stratum corneum,
the outermost skin layer, characterized by a robust structure
containing dense dead cells, corneocytes, which are embed-
ded in a continuous matrix of lipid bilayers. The tightly
packedstacksoflipidlamellaeintheextracellularspacemake
the stratum corneum a highly impermeable membrane [1].
Low permeability of the skin is also a limit for the transder-
maldrugdelivery,whichcouldrepresentavalidalternativeto
oraldeliveryandinjection.Adiversespectrumofmechanical
[2, 3], electrical [4], and chemical [5] techniques have
been previously explored to enhance skin permeability and,
consequently, to increase the transdermal drug transport.
Exposure to ultrasound (US) has also been shown to greatly
enhance the permeability of skin for permitting transdermal
drug delivery, a phenomenon termed sonophoresis [6–8].
Based on the frequency used, three types of US can be
applied to increase skin permeability: therapeutic US (from
1 to 3MHz), high-frequency US (above 3MHz), and low-
frequency US (20–100KHz). However, low-frequency US
h a v eb e e nf o u n dt ob em o r ee ﬃcient than high-frequency
US in inducing the transdermal transport [7, 8]. Previous
studies have demonstrated that the generation of gas bubbles
in the skin (cavitation) is the main mechanism responsible
for sonophoresis and is better induced by low-frequency
US, being inversely related to US frequency [9, 10]. The2 Journal of Biomedicine and Biotechnology
eﬃcacy of low-frequency US in inducing skin permeation is
proportional to their intensity. US intensities starting from
0.1W/cm2 are suﬃcient to permit the transdermal transport
across human skin of many permeants, including estradiol,
salicylic acid, corticosterone, and water [7, 11–13].
Other than representing the major barrier between the
body and the external environment, the skin provides a
complex microenvironment for the initiation and shaping of
T cell-mediated immune responses against microorganisms.
Among skin cell components, keratinocytes and dendritic
cells (DC), including epidermal Langerhans cells and der-
mal DC, are importantly involved in the induction and
ampliﬁcation of immune responses during inﬂammatory
skin reactions [14–16]. In particular, DC are specialized
to recognize and capture foreign antigens as well as to
activate na¨ ıve T cells, and resident keratinocytes contribute
to attract and retain discrete T-cell subsets into the skin.
In order to test whether US application could inﬂuence the
pathophysiological functions of skin cell components, we
investigated on the eﬀects of low-frequency US (42KHz)
administered at intensity ranging from 0.15 to 7W/cm2,o n
cultured keratinocyte and DC populations. In particular, we
examined the extracellular-signal-regulated kinase (ERK)1/2
activation, viability, and membrane molecule expression in
US-treatedkeratinocytes,and,inparallel,theirabilitytopro-
duce inﬂammatory molecules, such as immune-modulatory
membranemolecules,cytokines,andchemokines.Moreover,
we explored the possible US eﬀects on DC apoptosis,
immune phenotype and functions, including activation of
na¨ ıve T lymphocytes.
2.MaterialandMethods
2.1. US Generation and Application. The device generating
low-frequency US has been realized by Teuco Guzzini
technical laboratory (Montelupone, Macerata, Italy). US
were produced continuously with a frequency of 42KHz
by means of piezoelectric ceramic vibrating at its own
o d df r e q u e n c ya n dd r i v e nb yap o w e rs u p p l y .P i e z o e l e c t r i c
ceramics were placed under an acrylic basement, used as a
support for the cell culture plates, with an US transmission
gel (Transound, EF Medica, Bolzano, Italy) ﬁlm being
interposed to ensure US distribution. The distance between
the transducer ceramics and cell plate bottom was ∼ 0.3cm.
US emission was measured using a calibrated hydrophone
placed inside the culture medium. Treatments with US were
conducted for 7–21 minutes (1–3 cycles) at intensity ranging
from 0.15 to 7.0W/cm2.
2.2. Keratinocyte Cultures and Treatments. Normal human
keratinocytes were obtained from skin biopsies of healthy
volunteers (n = 3), as previously reported [17]. Brieﬂy,
biopsies were disaggregated to single-cell suspensions by
using six sequential treatments with 0.05% trypsin/0.02%
EDTA (InVitrogen Life Technology, Carlsbad, CA, USA),
each conducted for 30 minutes at 37◦C. Keratinocytes were
then counted and seeded in F75 ﬂasks on a ﬁbroblast 3T3
feeder layer previously treated with mitomycin C (Sigma-
Aldrich, Milan, Italy). Second or third passage keratinocytes
were used in all experiments, with cells cultured in 3cm-
diameterplatesinserum-freemedium(KeratinocyteGrowth
Medium, Clonetics, Walkersville, MD, USA), for at least 3–
5 days before performing experiments. Keratinocytes were
treated with US at a frequency of 42KHz for 1 cycle of 7
minutes or 3 cycles (in total 21 minutes). Some keratinocyte
cultures were in parallel stimulated with 200U/mL IFN-γ
plus 50ng/mL TNF-α (R&D Systems, Abingdon, Oxon,
United Kingdom) for 24 hours.
2.3. DC Preparations. DC were generated by culturing
monocytes, previously obtained from the adherent fraction
of peripheral blood mononuclear cells (PBMC) depleted of
CD2+, CD19+, and CD56+ cells by monoclonal antibody
(Ab)-coated immunomagnetic beads, in complete RPMI
1640 medium (Cambrex, East Rutherford, NJ), supple-
mented with 10% fetal bovine serum (Sigma-Aldrich) in
the presence of 200ng/mL GM-CSF (PeproTech, Rocky Hill,
NJ) and 200U/mL IL-4 (R&D Systems) at 37◦C. Medium
w a sr e p l a c e da f t e r3d a y sa n dc e l l sw e r eu s e da td a y7o f
culture. This procedure gave >97% pure CD1a+, CD14
−
DC preparations. To induce maturation, lipopolysaccharide
(LPS) (Sigma-Aldrich) was added at 50μg/mL for the last 24
h o u r so fD Cc u l t u r e .
2.4. Flow Cytometry Analysis. Keratinocyte expression of
membrane ICAM-1, HLA-DR, and integrins was evaluated
using ﬂuorescein isothiocyanate- (FITC-) conjugated anti-
CD54 (clone 84H10; Immunotech, Marseille, France), anti-
HLA-DR (clone L243, BD Pharmingen, Franklin Lakes, NJ,
USA), anti-human α6β4 integrin (clone JB1a, Chemicon,
Temecula, CA), and anti-human β1 integrin (clone S341)
monoclonal Abs. Apoptosis and necrosis of keratinocytes
and DC were evaluated using the Genzyme TACS Annexin
V apoptosis detection kit (R&D Systems). Activation of
caspase 9 in keratinocytes was revealed using the car-
boxyﬂuorescein FLICA assay kit (B-Bridge International,
Sunnyvale, CA). Mature DC previously treated or not with
USwerestainedwithFITC-conjugatedanti-CD80(MAB104,
IgG1,Immunotech),-CD83(HB15e,IgG1,BDPharMingen)
-CD86 (2331, IgG1, BD PharMingen), -CD40 (5C3, IgG1,
BD PharMingen), -HLA-DR (clone L243, BD PharMingen),
-CD1a (HI149, IgG1, BD PharMingen) Abs. In control sam-
ples, staining was performed using isotype-matched control
Abs. Cells were analyzed with a FACScan equipped with Cell
Quest software (Becton Dickinson, Mountain View, CA).
2.5. Enzyme-Linked Immunosorbent Assay (ELISA). Cell-
free supernatants from resting or stimulated keratinocyte
cultures were tested for CXCL10 content using the Ab
pair, the puriﬁed monoclonal Ab 4D5/A7/C5 for coating
and the biotinylated 6D4/D6/G2 (BD PharMingen, San
Diego, CA). CCL2 and CXCL8 were measured with OptEIA
kits (BD PharMingen), as per the manufacturer’s protocol.
TNF-α and IL-6 were assayed with DuoSet ELISA kits (R&D
Systems). DC supernatants collected from cultures 24 hours
after the US and LPS treatments were assayed for IL-12 p70
subunit, TNF-α, IL-6, and IL-10 contents using the DuoSet
ELISA kits (R&D Systems). The plates were analyzed inJournal of Biomedicine and Biotechnology 3
an ELISA reader (model 3550 UV, Bio-Rad, Hercules, CA).
Keratinocyte and DC cultures were performed in triplicate
for each condition. Results are given as mean ng or pg/106
cells ± SD.
2.6. Mixed Lymphocytes Reaction (MLR) Proliferation Assay.
In order to obtain responder population for the primary
MLR assay, T na¨ ıve lymphocytes were puriﬁed from allo-
geneic PBMC nonadherent fraction by using CD45RA
immunomagnetic microbeads (Miltenyi Biotec, Germany),
according to the manufacturer’ instructions. At day 5 of
culture, immature DC were left untreated or were treated
withUSatafrequencyof42KHzfor1–3cyclesbeforeadding
LPS for the next 24 hours. Untreated or US-treated mature
DC were then washed and cocultured in 96-well ﬂat bot-
tomed microplates in serial dilutions (0.625 to 10×103/well)
together with puriﬁed allogeneic T na¨ ıve lymphocytes (2 ×
105/well) in complete RPMI medium. Cocultures were
pulsed at day 5 with 2μCi/mL [3H]-thymidine (Amersham,
Little Chalfont, UK) for about 16 hours and then harvested
onto ﬁber-coated 96-well plates. Radioactivity (counts per
minute, CPM) was measured in a β-counter (Topcount;
Packard, Groningen, The Netherlands) and results were
given as the mean counts per minute ± SD of triplicate
cultures.
2.7.WesternBlottingandDensitometry. Protein extracts were
prepared by solubilizing cells in RIPA buﬀer (1% NP-40,
0.5% sodium dehoxycholate, 0.1% sodium dodecyl sulfate,
SDS) containing a mixture of protease and phosphatase
inhibitors. Proteins were subjected to SDS-PAGE, and trans-
ferred to polyvinylidene diﬂuoride membranes. The latter
were blocked, and probed with anti-ERK1/2 (C16; Santa
Cruz Biotechnology, Santa Cruz, CA, USA), anti-phospho-
ERK1/2 (E4; Santa Cruz Biotechnology), or with anti-β-
actin (C11; Santa Cruz Biotechnology) Abs diluted in PBS
containing 5% nonfat dried milk. Filters were developed
using the ECL-plus detection system (Amersham Pharmacia
Biotech, Buckinghamshire, UK), and, then, subjected to
densitometry using an Imaging Densitometer model GS-
710 (Bio-Rad) supported by the Molecular Analyst software,
and band intensities were evaluated in three independent
experiments. The densitometry values of phopsho-ERK1/2
were divided by the values of total ERK1/2 and, then, to β-
actin bands, and expressed as -fold induction (F. I.) ± SD
in experimental relative to untreated samples, to which were
given a value of 1.
2.8. Statistical Analysis. The Wilcoxon’s signed rank test was
used (SigmaStat, Jandel Co., San Rafael, CA) to compare the
apoptosis rate as well as the expression levels of membrane
molecules, phospho-ERK1/2, chemokines, and cytokines
between unstimulated and US-treated cells. P values ≤0.05
were considered signiﬁcant.
3. Results
3.1. ERK1/2 Activation, Viability, and Membrane Molecule
ExpressionIsNotAlteredinHumanKeratinocytesTreatedwith
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Figure 1: US at 42KHz and 0.15W/cm2 do not inﬂuence ERK1/2
levels in keratinocytes. Keratinocyte cultures treated with 1–3 cycles
of US or left untreated or activated with IFN-γ and TNF-α were
analyzedbyWesternblottinganalysisperformedwithanAbspeciﬁc
for both p42 and p44 ERK phosphorylated at Tyr 204 residue
(phospho-ERK1/2). Filters were stripped and reprobed with an
anti-ERK1/2 Ab. Equal loading of the samples was assayed probing
the ﬁlters using an Ab against the β-actin protein.
US at a Frequency of 42KHz and Intensity of 0.15W/cm2.
Although several studies have examined the eﬀects of US
application on whole skin [9, 11], evidence of US-induced
responses on the single cell components of the skin is
still limited. To this end, the eﬀects of low-frequency US
were analyzed on keratinocyte cultures established from
skin biopsies of healthy donors. US were employed on cell
cultures at frequency (42KHz) and intensity (0.15W/cm2)
values known to be eﬀective in enhancing human skin
permeation in vivo [12]. We ﬁrstly investigated on the US
eﬀects on keratinocyte expression and activation of ERK1/2
proteins, which sustain proliferative and self-protective
programs in keratinocytes [18]. As shown in Figure 1, the
phosphorylation status of ERK1/2 did not vary between
untreated and US-treated keratinocytes, although it was
upregulateduponIFN-γ andTNF-αtreatment,aspreviously
described [18]. Consistently, the levels of ERK1/2 total pro-
teins were unaﬀected by US irradiation. We, then, analyzed
keratinocyte viability by evaluating annexin V exposure on
plasmamembrane and propidium iodide (PI) incorporation
into DNA or caspase 9 expression. As positive control of
apoptosis, keratinocyte cultures were in parallel stimulated
with IFN-γ plus TNF-α. As shown in Figure 2(a),u p o n1 -
cycle or 3-cycle US stimulation the number of apoptotic
cells (lower and upper right quadrants) or necrotic cells
(upper left quadrant) was comparable to that observed in
untreated cultures. In contrast, an high number of apoptotic
and necrotic cells were induced by the IFN-γ plus TNF-α
treatment. The keratinocyte apoptotic rate was also assessed
by measuring the level of active caspase 9, a proteolytic
enzyme involved in the early phase of apoptotic processes,
whose expression was revealed using the ﬂuorescein-labeled
inhibitor FAM-LEHD-FMK. Stained apoptotic cells were
analyzed by ﬂow cytometry and, as shown in Figure 2(b),
only IFN-γ plus TNF-α treatments were able to induce
an high percentage (85%) of caspase 9-positive cells. In
contrast,both1-cycleand3-cycleUSdidnotmodifyviability4 Journal of Biomedicine and Biotechnology
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Figure 2: US at 42KHz and 0.15W/cm2 do not alter keratinocyte viability. (a) Keratinocyte cultures treated with 1–3 cycles of US or left
untreated were stained with annexin V and PI and analyzed by ﬂow cytometry. As expected, IFN-γ plus TNF-α treatment induced a high
percentage of necrotic (10.4%) and apoptotic (52.8%) cells. The x-axis and y-axis indicate the ﬂuorescence intensities of annexin V binding
and PI incorporation, respectively. (b) The keratinocyte apoptotic rate was also assessed by measuring caspase 9 expression, whose levels
were measured using the ﬂuorescein-labeled inhibitor FAM-LEHD-FMK and cytoﬂuorimetric analysis. Treatment of cultures with IFN-γ
plus TNF-α was able to induce a high percentage (85%) of caspase 9-positive cells (M1). The x-axis and y-axis indicate the relative cell
number and ﬂuorescence intensity, respectively. Representative experiment of ﬁve performed is shown.
of cells (Figure 2(b)). Moreover, treatment of keratinocytes
with 1 or 3 cycles of US at 42KHz did not alter the
surface expression of the β1a n dα6β4 integrins, essential
components of hemidesmosomes involved in the cell-cell
and cell-extracellular matrix adhesion of keratinocytes in
the epidermis [19]( Figure 3). Similarly, ICAM-1 and HLA-
DR, two membrane molecules involved in the retention
and activation of T lymphocytes during skin inﬂammatory
responses were also unaﬀected by US treatment, whereas
they were highly upregulated by IFN-γ and TNF-α,a s
previously reported [14].
3.2. Chemokine and Cytokine Release by Human Keratinocytes
Is Not Modiﬁed by US at 42KHz and 0.15W/cm2. Ker-
atinocytes can be activated by a variety of stimuli to produce
chemokines and cytokines important for the recruitment
and activation of immune cells and for the formation of a
T cell-rich inﬁltrate during skin diseases [14, 15]. In the next
seriesofexperimentswetestedwhetherUSstimulationcould
inﬂuence the release of chemokines, such as CXCL10, CCL2,
and CXCL8, abundantly expressed by keratinocytes activated
by IFN-γ and mostly by IFN-γ plus TNF-α. US-treated
keratinocytes cultures were also analyzed for the release
of the inﬂammatory cytokines IL-6 and TNF-α. Figure 4
shows that both 1-cycle and 3-cycle US at a frequency of
42KHz did not inﬂuence the release of the proinﬂammatory
chemokines CXCL10, CCL2 CXCL8 (Figures 4(a)–4(c))a n d
the cytokines IL-6 and TNF-α (Figures 4(d) and 4(e)),
all abundantly upregulated by keratinocytes when activated
with IFN-γ or IFN-γ plus TNF-α.
3.3. Treatment with US at 42KHz and 0.15W/cm2 Does
Not Induce Apoptosis and Necrosis of DC. The eﬀects of the
low-frequency US were also examined on DC, the skin cell
component representing the main mediator of inﬂammatory
responses during skin diseases [20]. DC can be generated
in vitro from peripheral blood or bone marrow progenitors.
In particular, circulating CD14+ monocytes, cultured in the
presence of GM-CSF and IL-4, can acquire many phenotyp-
ical features of primary DC, such as an increased expression
of immune membrane molecules, and become able to evoke
potentTcellresponses[16].ToinvestigatewhetherUSappli-
cation could inﬂuence the viability of DC population, we
analyzedmonocyte-derivedDCirradiatedwithUSat42KHz
frequency and 0.15W/cm2 intensity by performing the
trypan blue exclusion test or using the annexin V apoptosisJournal of Biomedicine and Biotechnology 5
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Figure 3: US at 42KHz and 0.15W/cm2 do not alter membrane molecule expression in human keratinocytes. Keratinocytes were analyzed
for β1a n dα6β4 integrins, ICAM-1 and HLA-DR expression by ﬂow cytometry after 1–3 cycles of US or treatment with IFN-γ plus TNF-α.
Dotted lines represent staining with matched isotype immunoglobulins. The x-axis and the y-axis indicate the relative cell number and
ﬂuorescence intensity, respectively.
detection system. Trypan blue assay demonstrated that both
1 cycle and 3 cycles of US stimulation did not signiﬁcantly
vary the number of viable cultured DC (viability superior to
93%; data not shown). Similar results were obtained by per-
forming annexin V and PI stainings. As shown in Figure 5,
after 3-cycle US stimulation, the number of annexin V+ or
annexin/PI+ apoptotic cells was similar to that observed for
untreatedcells(6.1% and5.4% versus7.9%and 5.3%, resp.).
Similarly, no signiﬁcant diﬀerence between US-treated and
untreated cells was detected in the number of necrotic cells
(5.4% versus 3.4%, resp.). These data exclude any deleterious
eﬀect of US treatment on DC viability and apoptosis.
3.4. Treatment with US at 42KHz and 0.15W/cm2 Does Not
Aﬀect Phenotype Nor Functional Maturation of DC. DC are
professionalantigenpresentingcellsabletogenerateprimary
immune responses. Under normal conditions, they reside
as immature DC in peripheral tissues where, after antigen
uptakeandexposuretoproinﬂammatorycytokines,undergo
maturation and migrate to local lymph nodes [16]. This
process is accompanied by functional and immunopheno-
typic changes characterized by the upregulation of MHC
classIIandcostimulatorymolecules,includingCD80,CD86,
and CD40, as well as by a substantial neoexpression of
CD83, a key marker of DC maturation [16]. Mature DC
enhance priming and activation of T lymphocytes and
vigorously stimulate antigen-speciﬁc T cell responses. Due
to the important role of DC on skin immune responses,
we examined the potential eﬀects of US on DC maturation,
evaluated in terms of CD40, CD80, CD83, CD86, HLA-
DR, and CD1a expression as well as their IL-12, TNF-α,I l -
6 and IL-10 release. To this end, 5-day cultured DC were6 Journal of Biomedicine and Biotechnology
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Figure 4: Chemokine and cytokine release by keratinocytes treated with US at 42KHz and 0.15W/cm2.C X C L 1 0( a ) ,C C L 2( b ) ,C X C L 8( c ) ,
IL-6 (d), and TNF-α (e). Concentrations were estimated by ELISA in supernatants of keratinocyte cultures treated with US or left untreated.
Soluble factor contents were also measured in supernatants of cells treated with IFN-γ alone or with IFN-γ plus TNF-α. Data are expressed
as mean nanograms or picograms per 106 cells ± SD of triplicate cultures.
exposed or not to 3-cycle US, and then 24 hours treated with
LPS, a potent stimulus for DC maturation. US treatment
of mature DC (LPS-treated) did not alter the expression of
the immune membrane molecule examined nor it modiﬁed
their cytokine release proﬁle (Figures 6 and 7). Finally, US
inﬂuenceonantigenpresentationabilityofDCwasevaluated
by analyzing the proliferation rate of na¨ ı v eTl y m p h o c y t e si n
allogeneicMLRassay.Thus,increasingamountsofuntreatedJournal of Biomedicine and Biotechnology 7
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Figure 5: US at 42KHz and 0.15W/cm2 do not alter DC viability. DC cultures treated with 3 cycles of US or left untreated were stained
with annexin V and PI and analyzed by ﬂow cytometry. The x-axis and y-axis indicate the ﬂuorescence intensities of annexin V binding and
PI incorporation, respectively. Annexin+ or annexin/PI+ DC represented early and late apoptotic DC, whereas PI+ DC were necrotic DC.
Representative experiment of ﬁve performed is shown.
or US-treated mature DC were cocultured with puriﬁed
naive T cells, and proliferation evaluated in terms of [3H]-
thymidine incorporation. As shown in Figure 8,1 – 3cy c leUS
stimulation did not inﬂuence the alloantigen-presentation
functionofmatureDC,whichinducedproliferationrateinT
cells similar to that observed for untreated cells. As a whole,
these data indicate that DC phenotype and function are not
altered by US stimulation.
3.5. Enhancement of Intensity of Low-Frequency US Alters
the Survival and Immune Responses of Keratinocytes and
DC. Previous studies demonstrated that the transdermal
transport rate across skin is proportional to US intensity,
although high-intensity US can produce signiﬁcant thermal
eﬀects leading to erythema and dermal necrosis [9]. In
order to identify a threshold value of US intensity at
which cell viability and immunological functions of cultured
keratinocytes and DC were altered and/or compromised,
we treated cells with low-frequency US at intensity ranging
from 0.15 to 7W/cm2. US-treated keratinocytes were, then,
analyzed for the exposure of apoptotic markers, ERK1/2
activation and the expression of immune mediators. DC
treatedwithUSatdiﬀerentintensitieswerealsoexaminedfor
apoptosis and immune phenotype. As shown in Table 1,U S
applied at intensities up to 2.3W/cm2 did not substantially
vary the apoptotic rate nor the levels of ERK1/2 activation
in cultured keratinocytes. In contrast, at the intensity value
of 5.0W/cm2, the number of apoptotic cells started to
increase (1.93-fold increase of apoptotic cell percentage
versus untreated samples, Table 1), and at 7.0W/cm2 cell
viability was greatly compromised (3.54-fold increase of
apoptotic cell percentage versus untreated samples, Table 1).
In parallel, we could observe a slight, but signiﬁcant, increase
of the adhesion molecules ICAM-1 and α6β4 integrin, but
not of HLA-DR in keratinocytes treated with US at the
highest intensity values (Table 1). Of note, keratinocytes
treated with US at 5 and 7W/cm2 showed an increase
of CXCL8 release as well as phospho-ERK1/2 expression
(Table 1). In addition, no substantial diﬀerences of CXCL10,
CCL2,IL-6,andTNF-αproductioncouldbeobservedinUS-
treated compared to unstimulated cells (Table 1). Similarly
to keratinocytes, DC showed an enhanced cell mortality
when treated with US at the highest intensities. In particular,
apoptotic DC started to accumulate upon treatment with US
at 5W/cm2 (1.94-fold increase compared to untreated DC,
Table 1), and substantially increase at 7.0W/cm2 (3.21-fold
increase compared to untreated DC, Table 1). Irradiation
with US at intensity of 5.0 and 7.0W/cm2 also determined
a slight but signiﬁcant increase of CD40 co-stimulatory
molecule (Table 1). In contrast, we could not detect any
variations in the expression of membrane CD1a, CD83,
CD80, HLA-DR, and CD86 by US-irradiated compared
t ou n t r e a t e dD C( Table 1). Finally, the enhancement of
intensity values of low-frequency US did not inﬂuence the
release of the cytokines TNF-α, IL-6, and IL-12 by both
immature (Table 1)a n dm a t u r eD C( d a t an o ts h o w n ) .
4. Discussion
Theskin represents anadvantageous portal fordrugdelivery,
and its exposure to US is considered as an useful tool to
enhance the transdermal transport by increasing cutaneous
permeability to a variety of therapeutics [6–8]. Although
sonophoresis has been a topic of extensive research in the last
15 years, information on US biological eﬀects on the single
skin cell components is limited. In this study, we investigated
whether application of low-frequency US inﬂuenced the
physiologicalandimmunefunctionsofhumankeratinocytes
and DC in vitro. Low-frequency US were used at frequency
(42KHz) and intensity (0.15W/cm2) values known to be8 Journal of Biomedicine and Biotechnology
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Figure 6: Treatment with USat 42KHzand 0.15W/cm2 does notchange phenotypic maturation of DC. DC were generated fromperipheral
blood monocytes cultured with GM-CSF and IL-4 for 6 days. At day 5, immature DC were treated or not with 3 cycles of US, and LPS
(50μg/mL) was added to promote maturation. After 24 hours incubation, DC were stained with FITC-conjugated Abs against the indicated
surface molecules. Thin and bold black lines indicate US-treated or untreated mature DC, respectively. Dotted lines represent staining with
matched isotype immunoglobulins. The x-axis and the y-axis indicate the relative cell number and ﬂuorescence intensity, respectively.Journal of Biomedicine and Biotechnology 9
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Figure 7: Treatment with US at 42KHz and 0.15W/cm2 does not
alter cytokine release from mature DC. 1–3 cycle US treatment was
performed on mature DC cultures, whose supernatants were tested
for IL-12, TNF-a, IL-6, and IL-10 content in ELISA. Results are
expressed as mean picograms per 106 cells per mL ± SD of triplicate
cultures.
eﬀective in enhancing human skin permeation in vivo [12].
It has been widely documented that, during inﬂammatory
skin reactions, following exposure to lymphokines, espe-
cially IFN-γ and TNF-α, epidermal keratinocytes become
an important source of inﬂammatory molecules [14, 15].
For instance, activated keratinocytes can express very high
levels of membrane molecules, including MHC Class II
and ICAM-1, as well as cytokines and chemokines, such
as CXCL8, responsible for the intraepidermal collection of
neutrophils, and CXCL10 and CCL2, both aimed at T-
cell recruitment [14]. In association to resident skin cells,
migrating immune cells play a central role, especially in the
initiation ofcutaneousinﬂammatoryresponses [16].Among
them, dermal DC, together with resident skin Langerhans
cells, can generate strong primary immune responses. DC
reside in an immature form inside unperturbed skin, where
they are adapted for capturing pathogens and processing
antigens, eventually becoming able to stimulate na¨ ıve T cell
proliferation and to promote T helper or cytotoxic responses
[16, 20].
In this study, we demonstrated that application of US at
42KHz and 0.15W/cm2 on cultured human keratinocytes
did not perturb their normal viability nor induce the
activation of ERK1/2 proteins, which are known to sustain
proliferative and self-protective programs in keratinocytes
[18]. In fact, the apoptotic and necrotic cell percentage as
well as the ERK1/2 phosphorylation status did not vary
between untreated and US-irradiated samples. In addition,
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Figure 8: DC treated with US at 42KHz and 0.15W/cm2 eﬃciently
induce na¨ ıve T cell responses. Mature DC were treated with 1-cycle
(square), 2-cycle (dot), or 3-cycle (triangle) US treatment or left
untreated. Graded numbers of DC (x-axis) were cocultured in 96-
well ﬂat bottomed microplates with 2×105/well puriﬁed CD45RA+
allogenic T cell, whose [3H]-thymidine incorporation (y-axis) was
measured after 5 days. Data are expressed as mean CPM ± SD of
triplicates cultures.
we demonstrated that US at 42KHz and 0.15W/cm2 did
not alter their phenotype, evaluated in terms of surface
expression of the β1a n dα6β4 integrins, two proteins
importantly involved in the formation of the epidermal
structure [20], and of ICAM-1 and HLA-DR, two typical
markers of immune-activated keratinocytes [14]. Moreover,
US administered at 42KHz and 0.15W/cm2 did not inﬂu-
ence the release of the chemokines CXCL10, CCL2, and
CXCL8, abundantly secreted by IFN-γ plus TNF-α-activated
keratinocytes, as well as the release of the cytokines IL-
6a n dT N F - α. However, we could also demonstrate that
irradiation of keratinocytes with low-frequency US set at
intensity values higher that 0.15W/cm2, namely, at 5 and
7W/cm2, determined substantial changes in survival and
immune molecule expression in these cells. In fact, in these
conditions, keratinocytes increased the apoptotic process
and also the expression of the adhesion molecules ICAM-1
and α6β4 integrin. Of note, at the US intensity value of 5
and7W/cm2,CXCL8andphospho-ERK1/2werealsoupreg-
ulated in keratinocytes. Since both CXCL8 and phospho-
ERK1/2 sustain keratinocyte growth and proliferation [14,
15, 18], the observed increase of these proteins could
be evoked to counteract the proapoptotic/necrotic eﬀects
induced by US at high intensities. All these data support and
are consistent with previous ﬁndings showing the safety of
the low-frequency US at low intensity values. In fact, Bou-
caud et al. using optical and electron microscopy, showed
that human skin samples exposed to US at intensities lower10 Journal of Biomedicine and Biotechnology
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than 2.5W/cm2 were morphologically similar to untreated
skin, and that histological alterations, such as detachment of
the epidermis and dermal necrosis, were detectable only after
an exposure to continuous US at 4W/cm2 [21]. In addition,
no substantial structural changes and modiﬁcations were
found in skin treated with US to enhance the topical
deliveryoftetanustoxoid[22]andantisenseoligonucleotides
[23]. Recently, it has been demonstrated that there is no
diﬀerenceinmorphologyandinmitogenicactivitiesbetween
US-treated and untreated skin-derived ﬁbroblasts [24]. On
the other hand, the enhancement of intensity of low-
frequency US did not alter either the expression of HLA-
DR, CXCL10, CCL2 or the proinﬂammatory cytokines IL-
6a n dT N F - α. Indeed, previous ﬁndings demonstrated that
US at a frequency of 1MHz could upregulate both IL-1α and
TNF-α in mouse epidermal keratinocytes in vivo, through
a mechanism involving the enhancement of local calcium
release [25]. This cytokine upregulation can also be due to
the fact that mice skin is extremely sensitive to US, even at a
lowfrequency,andresponds toUSwithimportantstructural
damages, including the detachment of the outer layer of the
stratum corneum and pore formation [26], in their whole
responsible for the epidermal upregulation of inﬂammatory
cytokines [27].
Similar to human keratinocytes, DC showed unaﬀected
viability, immune function, and phenotype in response to
US at 42KHz and 0.15W/cm2. In fact, annexin V/PI analysis
allowed us to exclude any cytotoxic or proapoptotic eﬀect
of US on DC. In parallel, we found that low-frequency low-
intensity US treatment did not inﬂuence the DC expression
of the membrane molecules CD40, CD80, CD83, CD86,
HLA-DR, and CD1a, or release of cytokines involved in DC
maturation. The latter include IL-6, TNF-α, IL-12, and IL-
10, which are crucial for driving diﬀerentiation of na¨ ıve T
cellstowardtheIFN-γ-producingtype1phenotype[20].DC
maturation correlates with their ability to present antigens
to T lymphocytes, and, indeed, we demonstrated that the
treatmentwithUSat42KHzand0.15W/cm2 did notimpair
the DC immunostimulatory activity, as assessed by analysing
the proliferation of allogeneic T lymphocytes in MLR assay.
To our knowledge, these ﬁndings are the ﬁrst demonstration
that low-frequency US do not potentially alter the immune
responses induced by DC and sustain the employment of US
as neutral transducer for the transcutaneous immunization
[21]. In fact, US have been used as physical adjuvant to
enhancethedelivery ofvaccines(i.e.,tetanus toxoid) into the
mouse skin and, thus, to generate potent systemic immune
responses [21]. In this vaccination system, other than
facilitating immunogen penetration, US appeared to activate
Langerhans cells, the antigen professional DC residing in
the epidermis. Indeed, Langerhans cells could be induced
to undergo maturation by the apoptotic bodies locally
released by dying cells rather than a direct eﬀect of US.
Consistently, another study reported that barrier disruption
induced Langerhans cell activation without migration to
regional lymph nodes [28]. By contrast, the enhancement of
US intensity to 5 and 7W/cm2 caused a substantial increase
of DC apoptotic rate. In these conditions, DC also showed
a slight but signiﬁcant increase of the expression of the co-
stimulatory molecule CD40, and no changes in the levels
of membrane CD1a, CD80, CD83, CD86, HLA-DR, nor of
secreted IL-12, IL-6, and TNF-α. The upregulation of CD40
on DC membrane, not accompanied by the increase of the
other stimulatory and co-stimulatory molecules, might not
signiﬁcantly inﬂuence T cell activation. However, further
studies are needed to deﬁnitively establish whether low-
frequency US at high intensities can inﬂuence DC-mediated
immune responses.
In conclusion, the data collected in this paper demon-
strate that US at low-frequency (42KHz) and low-intensity
(0.15W/cm2) do not inﬂuence cell viability and immune
functions of both keratinocytes and DC in vitro. Therefore,
our results sustain the safety of the in vivo application of US
having these physical parameters, as well as their employ-
ment for the transdermal delivery of drugs active in those
immune-mediated skin disorders where keratinocytes and
DC have a pathogenetic role. However, the enhancement of
the intensity of low-frequency US determines an increase of
the apoptotic rate of both keratinocytes and DC as well as of
keratinocyte self-protective responses and DC CD40 expres-
sion. We identify at 5W/cm2 the intensity value of low-
frequency US at which the viability and immune functions
of both keratinocytes and DC are altered in vitro. In order to
guarantee the safety of US application in vivo, further stud-
ies, performed by irradiating whole human skin with low-
frequency US at increasing intensities, and aimed at analyz-
ing keratinocyte and DC expression of cell viability markers
and immune-modulatory molecules, should be conducted.
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